Safety of aromatase inhibitors in the adjuvant setting

Por Perez, Edith A.
Publicado em 2007

Safety of aromatase inhibitors in the adjuvant setting

Por Perez, Edith A.
Publicado no Breast Cancer Res Treat (2007)

How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?

Por Norton, Nadine, Perez, Edith A
Publicado em 2013

Managing the Early and Locally Advanced Breast Cancer Patient at High Risk for Recurrence: Recent Advances and Nursing Implications

Por Palmieri, Frances M., Perez, Edith A.
Publicado em 2007

Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane

Por Moreno-Aspitia, Alvaro, Perez, Edith A.
Publicado em 2009

Treatment options for patients with triple-negative breast cancer

Por Santana-Davila, Rafael, Perez, Edith A
Publicado em 2010

Aromatase Inhibitors and Bone Loss

Por PEREZ, EDITH A., M., Serene, Durling, Frances C., WEILBAECHER, KATHERINE
Publicado em 2006

Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries

Por Zhu, Wenjie, Perez, Edith A., Hong, Ruoxi, Li, Qing, Xu, Binghe
Publicado no PLoS One (2015)

Adjuvant Therapy of Triple Negative Breast Cancer

Por Perez, Edith A., Moreno-Aspitia, Alvaro, Thompson, E. Aubrey, Andorfer, Cathy A.
Publicado em 2010

Breast Cancer in Latinas: Gene Expression, Differential Response to Treatments, and Differential Toxicities in Latinas Compared with Other Population Groups

Por Patel, Tejal A., Colon-Otero, Gerardo, Bueno Hume, Celyne, Copland, John A., Perez, Edith A.
Publicado em 2010

Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial

Por Advani, Pooja P., Ballman, Karla V., Dockter, Travis J., Colon-Otero, Gerardo, Perez, Edith A.
Publicado no J Clin Oncol (2016)

p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression

Por Soto, Edwin, Yanagisawa, Masahiro, Marlow, Laura A., Copland, John A., Perez, Edith A., Anastasiadis, Panos Z.
Publicado em 2008

Effective Targeting of Estrogen Receptor Negative Breast Cancers with the Protein Kinase D inhibitor CRT0066101

Por Borges, Sahra, Perez, Edith A., Thompson, E. Aubrey, Radisky, Derek C., Geiger, Xochiquetzal J., Storz, Peter
Publicado no Mol Cancer Ther (2015)

Erratum to: Dual HER2 blockade: preclinical and clinical data

Por Patel, Tejal A, Dave, Bhuvanesh, Rodriguez, Angel A, Chang, Jenny C, Perez, Edith A, Colon-Otero, Gerardo
Publicado no Breast Cancer Res (2014)

Dual HER2 blockade: preclinical and clinical data

Por Patel, Tejal A, Dave, Bhuvanesh, Rodriguez, Angel A, Chang, Jenny C, Perez, Edith A, Colon-Otero, Gerardo
Publicado no Breast Cancer Res (2014)

Effect of Body Mass Index (BMI) on Tumor Characteristics and Disease-Free Survival in Patients from the HER2-Positive Adjuvant Trastuzumab Trial N9831

Por Crozier, Jennifer A., Moreno-Aspitia, Alvaro, Ballman, Karla V., Dueck, Amylou C., Pockaj, Barbara A., Perez, Edith A.
Publicado em 2013

Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patient...

Por Perez, Edith A, Hurvitz, Sara A, Amler, Lukas C, Mundt, Kirsten E, Ng, Vivian, Guardino, Ellie, Gianni, Luca
Publicado no Breast Cancer Res (2014)

A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast canc...

Por Li, Tianhong, Guo, Mengye, Gradishar, William J., Sparano, Joseph A., Perez, Edith A., Wang, Molin, Sledge, George W.
Publicado no Breast Cancer Res Treat (2012)

Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer

Por Perez, Edith A., Ballman, Karla V., Tenner, Kathy S., Thompson, E. Aubrey, Badve, Sunil S., Bailey, Helen, Baehner, Frederick L.
Publicado no JAMA Oncol (2016)

Increased Incidence of Loco-Regional Recurrences Among African American Women with Terminal Stage Breast Cancer

Por Colón-Otero, Gerardo, King, Sherry, Smith, Vandelyn, Bieber, Carolyn, Crook, Julia, Solberg, Lawrence A., Shannon, Robert, Perez, Edith A.
Publicado em 2008